The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
Open accessAbstract
Diabetes compromises bone cell metabolism and function, resulting in increased risk of fragility fracture. Advanced glycation end products (AGEs) interact with the receptor for AGEs (RAGE) and can make a meaningful contribution to bone cell metabolism and/or alter function. Searches in PubMed using the key words “advanced glycation end-product,” “RAGE,” “sRAGE,” “bone,” and “diabetes” were made to explain some of the clinical outcomes of diabetes in bone metabolism through the AGE–RAGE signaling pathway. All published clinical studies were included in tables. The AGE–RAGE signaling pathway participates in diabetic complications, including diabetic osteopathy. Some clinical results in diabetic patients, such as reduced bone density, suppressed bone turnover markers, and bone quality impairment, could be potentially due to AGE–RAGE signaling consequences. However, the AGE–RAGE signaling pathway has some helpful roles in the bone, including an increase in osteogenic function. Soluble RAGE (sRAGE), as a ligand decoy, may increase in either conditions of RAGE production or destruction, and then it cannot always reflect the AGE–RAGE signaling. Recombinant sRAGE can block the AGE–RAGE signaling pathway but is associated with some limitations, such as accessibility to AGEs, an increase in other RAGE ligands, and a long half-life (24 hours), which is associated with losing the beneficial effect of AGE/RAGE. As a result, sRAGE is not a helpful marker to assess activity of the RAGE signaling pathway. The recombinant sRAGE cannot be translated into clinical practice due to its limitations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normal Bone Anatomy and Physiology
Clarke, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04151206 · Cited by 2,192 · cited 2×
“Osteoblasts produce bone matrix proteins, including type I collagen [55, 56].”
BackgroundRole of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150 · cited 5×
“Furthermore, the important part of RAGE for interaction with RAGE ligands is the variable domain [6, 11], which is AGE specific, and AGEs are generally complex and heterogenic compounds [7].”
BackgroundInfluentialRamasamy, R., Vannucci, S. J., Yan, S. S. D., Herold, K., Yan, S. F., & Schmidt, A. M. (2005) · Glycobiology · doi:10.1093/glycob/cwi053 · Cited by 834
Use of bone turnover markers in postmenopausal osteoporosis
Eastell, R., & Szulc, P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30184-5 · Cited by 594
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357
Kumar Pasupulati, A., Chitra, P. S., & Reddy, G. B. (2016) · Biomolecular Concepts · doi:10.1515/bmc-2016-0021 · Cited by 163 · cited 3×
“sRAGE can bind AGEs without inducing intrinsic signals, due to lacking internal and/or transmembrane parts of the RAGE, leads to potential blocking of AGE–RAGE interaction, and so plays a protective role in the setting of RAGE accumulation [17, 18].”
BackgroundHMGB1 Regulates RANKL-Induced Osteoclastogenesis in a Manner Dependent on RAGE
Zhou, Z., Han, J.-Y., Xi, C.-X., Xie, J.-X., Feng, X., Wang, C.-Y., Mei, L., & Xiong, W.-C. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080234 · Cited by 160 · cited 15×
“The pathophysiology of bone impairment includes compromised bone metabolism (due to oxidant injury, lower IGF-1, higher sclerostin, and lower circulating osteoprogenitor cells), impairment of cell function, Abbreviations: ADAM10, a disintegrin and metalloproteinase domain-containing protein 10; AGE, advanced glycation…”
InfluentialAPPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner
Cui, S., Xiong, F., Hong, Y., Jung, J.-U., Li, X.-S., Liu, J.-Z., Yan, R., Mei, L., Feng, X., & Xiong, W.-C. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.299 · Cited by 101
Okazaki, K., Yamaguchi, T., Tanaka, K.-I., Notsu, M., Ogawa, N., Yano, S., & Sugimoto, T. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9641-2 · Cited by 98
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
Leung, C., Herath, C. B., Jia, Z., Andrikopoulos, S., Brown, B. E., Davies, M. J., Rivera, L. R., Furness, J. B., Forbes, J. M., & Angus, P. W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i35.8026 · Cited by 80
Li, G., Xu, J., & Li, Z. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.015 · Cited by 65
Zhu, S., Zhuang, J., Wu, Q., Liu, Z., Liao, C., Luo, S., Chen, J., & Zhong, Z. (2018) · Aging Cell · doi:10.1111/acel.12764 · Cited by 55
RAGE Signaling in Skeletal Biology
Plotkin, L. I., Essex, A. L., & Davis, H. M. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00499-w · Cited by 54
Lopez‐Moreno, J., Quintana‐Navarro, G. M., Camargo, A., Jimenez‐Lucena, R., Delgado‐Lista, J., Marin, C., Tinahones, F. J., Striker, G. E., Roche, H. M., Perez‐Martinez, P., et al. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201601029 · Cited by 41
Liu, J., Mao, J., Jiang, Y., Xia, L., Mao, L., Wu, Y., Ma, P., & Fang, B. (2016) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1925-3 · Cited by 30
Galliera, E., Marazzi, M. G., Gazzaruso, C., Gallotti, P., Coppola, A., Montalcini, T., Pujia, A., & Corsi Romanelli, M. M. (2017) · Immunity & Ageing · doi:10.1186/s12979-017-0097-0 · Cited by 18
Cited by
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
Perrone, A., Giovino, A., Benny, J., & Martinelli, F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3818196 · Cited by 459
Darenskaya, M. A., Kolesnikova, L. I., & Kolesnikov, S. I. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05191-7 · Cited by 446
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
Wang, L., Li, Y., Ren, M., Wang, X., Li, L., Liu, F., Lan, Y., Yang, S., & Song, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.008 · Cited by 91
Metadata
- Authors
- Asadipooya, K., & Uy, E. M.
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2019-07-10
- Volume
- 3
- Issue
- 10
- Pages
- 1799-1818
- ISSN
- 2472-1972 (ISSN-L)
- OpenAlex
- W2956714488
- Cited by
- 225
- References
- 16
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.